Projects

Ing. Silvia Jochová, PhD.

International

Finished
  • Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe
    Program: Horizon 2020
    Duration: 1. 5. 2021 – 30. 4. 2024

National

Finished
  • Identification of chemoresistant cell populations with metastatic potential in colorectal carcinoma
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Markers overlapping chemoresistance and metastatic potential in colorectal cancer - aldehyde dehydrogenase and its clinical relevance
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • Mechanism of the mesenchymal stromal cell-induced tolerance to antitumor treatment and targeted therapeutic intervention in the breast cancer cells
    Program: SRDA
    Duration: 1. 7. 2017 – 31. 12. 2021
  • Cellular and molecular traits of human metastasis-initiating cells at different stages of metastasis development.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Therapeutic targeting of cancer stem cell markers circumventing cisplatin resistance in testicular germ cell tumors
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 12. 2020
  • Study of the mechanisms blocking tumorigenicity of cancer cells overexpressing human tumor necrosis factor alpha.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • The role of CA IX in adaptation to tumor microenvironment and in resistance to anticancer therapy: molecular mechanisms and clinical implications
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Role of Stress Response Induced in Mesenchymal Stromal Cells in Extrinsic Drug Resistance of Human Tumor Cells
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
Employees